Index by Author

May 1996; 19 (5)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Anglin, K

    • Effectiveness of a behavioral weight control program for blacks and whites with NIDDM. Diabetes Care May 1996 19:409-413; doi:10.2337/diacare.19.5.409

  2. Aro, S

    • Structure and costs of health care of diabetic patients in Finland. Diabetes Care May 1996 19:494-497; doi:10.2337/diacare.19.5.494

B

  1. Barrett-Connor, E

    • GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care May 1996 19:450-456; doi:10.2337/diacare.19.5.450

  2. Bastyr, E J

    • Latex allergen allergic reactions. Diabetes Care May 1996 19:546

  3. Bell, D S

    • Alcohol and the NIDDM patient. Diabetes Care May 1996 19:509-513; doi:10.2337/diacare.19.5.509

  4. Bellini, C

    • Endogenous insulin modulates circulating endothelin-1 concentrations in humans. Diabetes Care May 1996 19:504-506; doi:10.2337/diacare.19.5.504

  5. Bilo, H J

    • Orthostatic hypotension in poorly regulated NIDDM. Diabetes Care May 1996 19:542

  6. Bloomgarden, Z T

    • 1995 EASD meetings. Immunology, insulin, amylin, obesity, retinopathy, and neuropathy. Diabetes Care May 1996 19:550-554

  7. Brancati, F L

    • A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care May 1996 19:414-418; doi:10.2337/diacare.19.5.414
    • Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators. Diabetes Care May 1996 19:480-485; doi:10.2337/diacare.19.5.480

  8. Braun, B

    • Risk factors for diabetes and cardiovascular disease in young Australian aborigines. A 5-year follow-up study. Diabetes Care May 1996 19:472-479; doi:10.2337/diacare.19.5.472

  9. Buchanan, T A

    • Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care May 1996 19:514-541

C

  1. Cai, J

    • Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators. Diabetes Care May 1996 19:480-485; doi:10.2337/diacare.19.5.480

  2. Chaturvedi, N

    • The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study. Diabetes Care May 1996 19:423-430; doi:10.2337/diacare.19.5.423

  3. Chuang, L M

    • No association between the Gly971Arg variant of the insulin receptor substrate 1 gene and NIDDM in the Taiwanese population. Diabetes Care May 1996 19:446-449; doi:10.2337/diacare.19.5.446

  4. Ciardullo, A V

    • Does a high-carbohydrate diet have different effects in NIDDM patients treated with diet alone or hypoglycemic drugs? Diabetes Care May 1996 19:498-500; doi:10.2337/diacare.19.5.498

  5. Clandinin, M T

    • A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care May 1996 19:463-467; doi:10.2337/diacare.19.5.463

  6. Combs, C A

    • Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care May 1996 19:514-541

  7. Connolly, V M

    • Socioeconomic status and clustering of cardiovascular disease risk factors in diabetic patients. Diabetes Care May 1996 19:419-422; doi:10.2337/diacare.19.5.419

D

  1. De Mattia, G

    • Endogenous insulin modulates circulating endothelin-1 concentrations in humans. Diabetes Care May 1996 19:504-506; doi:10.2337/diacare.19.5.504

  2. Deckert, T

    • Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study. Diabetes Care May 1996 19:435-440; doi:10.2337/diacare.19.5.435

  3. Desideri, G

    • Endogenous insulin modulates circulating endothelin-1 concentrations in humans. Diabetes Care May 1996 19:504-506; doi:10.2337/diacare.19.5.504

  4. Doelman, C J

    • Orthostatic hypotension in poorly regulated NIDDM. Diabetes Care May 1996 19:542

  5. Dowse, G K

    • A case-control study of diet in newly diagnosed NIDDM in the Wanigela people of Papua New Guinea. Diabetes Care May 1996 19:457-462; doi:10.2337/diacare.19.5.457

  6. Duncan, B B

    • A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care May 1996 19:414-418; doi:10.2337/diacare.19.5.414

  7. de Groot, R R

    • Trends in hospital admissions among children aged 0-19 years with type I diabetes in The Netherlands. Diabetes Care May 1996 19:431-434; doi:10.2337/diacare.19.5.431

E

  1. Edelstein, S

    • GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care May 1996 19:450-456; doi:10.2337/diacare.19.5.450

  2. Elbein, S C

    • Role of mitochondrial DNA tRNA leucine and glucagon receptor missense mutations in Utah white diabetic patients. Diabetes Care May 1996 19:507-508; doi:10.2337/diacare.19.5.507

F

  1. Ferri, C

    • Endogenous insulin modulates circulating endothelin-1 concentrations in humans. Diabetes Care May 1996 19:504-506; doi:10.2337/diacare.19.5.504

  2. Finegood, D T

    • A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care May 1996 19:463-467; doi:10.2337/diacare.19.5.463

  3. Folsom, A R

    • Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators. Diabetes Care May 1996 19:480-485; doi:10.2337/diacare.19.5.480

  4. Fuller, J H

    • The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study. Diabetes Care May 1996 19:423-430; doi:10.2337/diacare.19.5.423

G

  1. Giacco, R

    • Does a high-carbohydrate diet have different effects in NIDDM patients treated with diet alone or hypoglycemic drugs? Diabetes Care May 1996 19:498-500; doi:10.2337/diacare.19.5.498

  2. Gosling, R G

    • A family history of NIDDM is associated with decreased aortic distensibility in normal healthy young adult subjects. Diabetes Care May 1996 19:501-503; doi:10.2337/diacare.19.5.501

  3. Gracey, M

    • Risk factors for diabetes and cardiovascular disease in young Australian aborigines. A 5-year follow-up study. Diabetes Care May 1996 19:472-479; doi:10.2337/diacare.19.5.472

  4. Green, G M

    • Rapid gastric emptying of a solid pancake meal in type II diabetic patients. Diabetes Care May 1996 19:468-471; doi:10.2337/diacare.19.5.468

  5. Guan, D

    • Rapid gastric emptying of a solid pancake meal in type II diabetic patients. Diabetes Care May 1996 19:468-471; doi:10.2337/diacare.19.5.468

  6. Guerrero-Romero, F

    • Prevalence of NIDDM in indigenous communities of Durango, Mexico. Diabetes Care May 1996 19:547-548

H

  1. Heiss, G

    • A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care May 1996 19:414-418; doi:10.2337/diacare.19.5.414

  2. Hirasing, R A

    • Trends in hospital admissions among children aged 0-19 years with type I diabetes in The Netherlands. Diabetes Care May 1996 19:431-434; doi:10.2337/diacare.19.5.431

  3. Hodge, A M

    • A case-control study of diet in newly diagnosed NIDDM in the Wanigela people of Papua New Guinea. Diabetes Care May 1996 19:457-462; doi:10.2337/diacare.19.5.457

  4. Hoffman, M D

    • Role of mitochondrial DNA tRNA leucine and glucagon receptor missense mutations in Utah white diabetic patients. Diabetes Care May 1996 19:507-508; doi:10.2337/diacare.19.5.507

  5. Hopkins, K D

    • A family history of NIDDM is associated with decreased aortic distensibility in normal healthy young adult subjects. Diabetes Care May 1996 19:501-503; doi:10.2337/diacare.19.5.501

J

  1. Jensen, J S

    • Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study. Diabetes Care May 1996 19:435-440; doi:10.2337/diacare.19.5.435

  2. Jones, R L

    • A family history of NIDDM is associated with decreased aortic distensibility in normal healthy young adult subjects. Diabetes Care May 1996 19:501-503; doi:10.2337/diacare.19.5.501

  3. Jumpson, J

    • A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care May 1996 19:463-467; doi:10.2337/diacare.19.5.463

K

  1. Kangas, T

    • Structure and costs of health care of diabetic patients in Finland. Diabetes Care May 1996 19:494-497; doi:10.2337/diacare.19.5.494

  2. Kesson, C M

    • Socioeconomic status and clustering of cardiovascular disease risk factors in diabetic patients. Diabetes Care May 1996 19:419-422; doi:10.2337/diacare.19.5.419

  3. Kitzmiller, J L

    • Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care May 1996 19:514-541

  4. Kjos, S

    • Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care May 1996 19:514-541

  5. Koivisto, V A

    • Structure and costs of health care of diabetic patients in Finland. Diabetes Care May 1996 19:494-497; doi:10.2337/diacare.19.5.494

  6. Kretchmer, N

    • Risk factors for diabetes and cardiovascular disease in young Australian aborigines. A 5-year follow-up study. Diabetes Care May 1996 19:472-479; doi:10.2337/diacare.19.5.472

L

  1. Laakso, M

    • Structure and costs of health care of diabetic patients in Finland. Diabetes Care May 1996 19:494-497; doi:10.2337/diacare.19.5.494

  2. Lai, C S

    • No association between the Gly971Arg variant of the insulin receptor substrate 1 gene and NIDDM in the Taiwanese population. Diabetes Care May 1996 19:446-449; doi:10.2337/diacare.19.5.446

  3. Lehmann, E D

    • A family history of NIDDM is associated with decreased aortic distensibility in normal healthy young adult subjects. Diabetes Care May 1996 19:501-503; doi:10.2337/diacare.19.5.501

  4. Lin, B J

    • No association between the Gly971Arg variant of the insulin receptor substrate 1 gene and NIDDM in the Taiwanese population. Diabetes Care May 1996 19:446-449; doi:10.2337/diacare.19.5.446

M

  1. Mathiesen, E R

    • Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study. Diabetes Care May 1996 19:435-440; doi:10.2337/diacare.19.5.435

  2. Matsunuma, A

    • A pitfall in the association study of ACE gene polymorphism. Diabetes Care May 1996 19:543-544
    • Gly40Ser substitution in the glucagon receptor is rarely involved in the pathogenesis of NIDDM in Japanese patients. Diabetes Care May 1996 19:547

  3. Mavo, B

    • A case-control study of diet in newly diagnosed NIDDM in the Wanigela people of Papua New Guinea. Diabetes Care May 1996 19:457-462; doi:10.2337/diacare.19.5.457

  4. McMahan, C A

    • Rapid gastric emptying of a solid pancake meal in type II diabetic patients. Diabetes Care May 1996 19:468-471; doi:10.2337/diacare.19.5.468

  5. McManus, R M

    • A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care May 1996 19:463-467; doi:10.2337/diacare.19.5.463

  6. Meneilly, G S

    • Pancreatic polypeptide responses to hypoglycemia in aging and diabetes. Diabetes Care May 1996 19:544-546

  7. Miedema, K

    • Orthostatic hypotension in poorly regulated NIDDM. Diabetes Care May 1996 19:542

  8. Montgomery, J

    • A case-control study of diet in newly diagnosed NIDDM in the Wanigela people of Papua New Guinea. Diabetes Care May 1996 19:457-462; doi:10.2337/diacare.19.5.457

  9. Myrup, B

    • Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study. Diabetes Care May 1996 19:435-440; doi:10.2337/diacare.19.5.435
    • Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy. Diabetes Care May 1996 19:441-445; doi:10.2337/diacare.19.5.441

N

  1. Nabulsi, A A

    • Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators. Diabetes Care May 1996 19:480-485; doi:10.2337/diacare.19.5.480

  2. Niskanen, L K

    • Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Diabetes Care May 1996 19:486-493; doi:10.2337/diacare.19.5.486

O

  1. Odawara, M

    • A pitfall in the association study of ACE gene polymorphism. Diabetes Care May 1996 19:543-544
    • Gly40Ser substitution in the glucagon receptor is rarely involved in the pathogenesis of NIDDM in Japanese patients. Diabetes Care May 1996 19:547

  2. Ostergaard, P B

    • Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy. Diabetes Care May 1996 19:441-445; doi:10.2337/diacare.19.5.441

  3. Oude Elberink, J N

    • Orthostatic hypotension in poorly regulated NIDDM. Diabetes Care May 1996 19:542

P

  1. Parillo, M

    • Does a high-carbohydrate diet have different effects in NIDDM patients treated with diet alone or hypoglycemic drugs? Diabetes Care May 1996 19:498-500; doi:10.2337/diacare.19.5.498

  2. Park, S

    • GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care May 1996 19:450-456; doi:10.2337/diacare.19.5.450

  3. Parviainen, M

    • Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Diabetes Care May 1996 19:486-493; doi:10.2337/diacare.19.5.486

  4. Penttilã, I

    • Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Diabetes Care May 1996 19:486-493; doi:10.2337/diacare.19.5.486

  5. Phillips, W T

    • Rapid gastric emptying of a solid pancake meal in type II diabetic patients. Diabetes Care May 1996 19:468-471; doi:10.2337/diacare.19.5.468

R

  1. Ratner, R E

    • Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care May 1996 19:514-541

  2. Reeser, H M

    • Trends in hospital admissions among children aged 0-19 years with type I diabetes in The Netherlands. Diabetes Care May 1996 19:431-434; doi:10.2337/diacare.19.5.431

  3. Reunanen, A

    • Structure and costs of health care of diabetic patients in Finland. Diabetes Care May 1996 19:494-497; doi:10.2337/diacare.19.5.494

  4. Riccardi, G

    • Does a high-carbohydrate diet have different effects in NIDDM patients treated with diet alone or hypoglycemic drugs? Diabetes Care May 1996 19:498-500; doi:10.2337/diacare.19.5.498

  5. Rivellese, A A

    • Does a high-carbohydrate diet have different effects in NIDDM patients treated with diet alone or hypoglycemic drugs? Diabetes Care May 1996 19:498-500; doi:10.2337/diacare.19.5.498

  6. Robinson, J C

    • Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators. Diabetes Care May 1996 19:480-485; doi:10.2337/diacare.19.5.480

  7. Rodríguez-Moran, M

    • Prevalence of NIDDM in indigenous communities of Durango, Mexico. Diabetes Care May 1996 19:547-548

  8. Rossing, P

    • Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy. Diabetes Care May 1996 19:441-445; doi:10.2337/diacare.19.5.441

  9. Ruwaard, D

    • Trends in hospital admissions among children aged 0-19 years with type I diabetes in The Netherlands. Diabetes Care May 1996 19:431-434; doi:10.2337/diacare.19.5.431

  10. Ryan, E A

    • A comparison of the effects of n-3 fatty acids from linseed oil and fish oil in well-controlled type II diabetes. Diabetes Care May 1996 19:463-467; doi:10.2337/diacare.19.5.463

  11. Rønn, B

    • Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study. Diabetes Care May 1996 19:435-440; doi:10.2337/diacare.19.5.435

S

  1. Salinto, M

    • Structure and costs of health care of diabetic patients in Finland. Diabetes Care May 1996 19:494-497; doi:10.2337/diacare.19.5.494

  2. Sandoval-Herrera, F

    • Prevalence of NIDDM in indigenous communities of Durango, Mexico. Diabetes Care May 1996 19:547-548

  3. Santucci, A

    • Endogenous insulin modulates circulating endothelin-1 concentrations in humans. Diabetes Care May 1996 19:504-506; doi:10.2337/diacare.19.5.504

  4. Schmidt, M I

    • A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care May 1996 19:414-418; doi:10.2337/diacare.19.5.414

  5. Schwartz, J G

    • Rapid gastric emptying of a solid pancake meal in type II diabetic patients. Diabetes Care May 1996 19:468-471; doi:10.2337/diacare.19.5.468

  6. Shan, J

    • GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care May 1996 19:450-456; doi:10.2337/diacare.19.5.450

  7. Sharrett, A R

    • A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care May 1996 19:414-418; doi:10.2337/diacare.19.5.414

  8. Smith, R M

    • Risk factors for diabetes and cardiovascular disease in young Australian aborigines. A 5-year follow-up study. Diabetes Care May 1996 19:472-479; doi:10.2337/diacare.19.5.472

  9. Spargo, R M

    • Risk factors for diabetes and cardiovascular disease in young Australian aborigines. A 5-year follow-up study. Diabetes Care May 1996 19:472-479; doi:10.2337/diacare.19.5.472

  10. Stephenson, J M

    • The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study. Diabetes Care May 1996 19:423-430; doi:10.2337/diacare.19.5.423

T

  1. Tai, T Y

    • No association between the Gly971Arg variant of the insulin receptor substrate 1 gene and NIDDM in the Taiwanese population. Diabetes Care May 1996 19:446-449; doi:10.2337/diacare.19.5.446

  2. Turay, R C

    • A family history of NIDDM is associated with decreased aortic distensibility in normal healthy young adult subjects. Diabetes Care May 1996 19:501-503; doi:10.2337/diacare.19.5.501

U

  1. Uusitupa, M I

    • Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Diabetes Care May 1996 19:486-493; doi:10.2337/diacare.19.5.486

V

  1. Verloove-Vanhorick, S P

    • Trends in hospital admissions among children aged 0-19 years with type I diabetes in The Netherlands. Diabetes Care May 1996 19:431-434; doi:10.2337/diacare.19.5.431

  2. van Buuren, S

    • Trends in hospital admissions among children aged 0-19 years with type I diabetes in The Netherlands. Diabetes Care May 1996 19:431-434; doi:10.2337/diacare.19.5.431

W

  1. Watson, R

    • Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The Atherosclerosis Risk in Communities Study Investigators. Diabetes Care May 1996 19:480-485; doi:10.2337/diacare.19.5.480

  2. Watson, R L

    • A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care May 1996 19:414-418; doi:10.2337/diacare.19.5.414

  3. Watt, T

    • A case-control study of diet in newly diagnosed NIDDM in the Wanigela people of Papua New Guinea. Diabetes Care May 1996 19:457-462; doi:10.2337/diacare.19.5.457

  4. Wing, R R

    • Effectiveness of a behavioral weight control program for blacks and whites with NIDDM. Diabetes Care May 1996 19:409-413; doi:10.2337/diacare.19.5.409

  5. Wingard, D L

    • GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care May 1996 19:450-456; doi:10.2337/diacare.19.5.450

  6. Wu, H P

    • No association between the Gly971Arg variant of the insulin receptor substrate 1 gene and NIDDM in the Taiwanese population. Diabetes Care May 1996 19:446-449; doi:10.2337/diacare.19.5.446

Y

  1. Yamashita, K

    • A pitfall in the association study of ACE gene polymorphism. Diabetes Care May 1996 19:543-544
    • Gly40Ser substitution in the glucagon receptor is rarely involved in the pathogenesis of NIDDM in Japanese patients. Diabetes Care May 1996 19:547

  2. Yeh, J I

    • No association between the Gly971Arg variant of the insulin receptor substrate 1 gene and NIDDM in the Taiwanese population. Diabetes Care May 1996 19:446-449; doi:10.2337/diacare.19.5.446

  3. Yokoyama, H

    • Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study. Diabetes Care May 1996 19:435-440; doi:10.2337/diacare.19.5.435
    • Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy. Diabetes Care May 1996 19:441-445; doi:10.2337/diacare.19.5.441

Z

  1. Zimmermann, M B

    • Risk factors for diabetes and cardiovascular disease in young Australian aborigines. A 5-year follow-up study. Diabetes Care May 1996 19:472-479; doi:10.2337/diacare.19.5.472

  2. Zimmet, P Z

    • A case-control study of diet in newly diagnosed NIDDM in the Wanigela people of Papua New Guinea. Diabetes Care May 1996 19:457-462; doi:10.2337/diacare.19.5.457

Current Issue

  1. March 2010, 33 (3)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care